Overview

Why care today

5 signals from free data

Past 1Y+155.2%1M -0.8% · 3M -0.7%

Analyst target+21.6%Target $36.53 · 9 analysts

Strong valuation100Top pillar on the scorecard

Revenue YoY-71.6%Top line going backwards

Institutional80.5%Footprint of total float

Where it sits today

52-week price range

Low$10.71

High$32.79

Today $30.04

RSI (14)

55.3Neutral

OversoldHealthyOverbought

Key stats

Market cap$20.56B

P/E (TTM)0

EPS next Y+21.8%

Reco score1.29

Avg target$36.53

Implied upside+21.6%

Analysts9

52W high$32.79

52W low$10.71

Div yield0.0%

Beta1.14

Returns

Price action

1 month

-0.8%

3 months

-0.7%

6 months

+38.1%

1 year

+155.2%

Who owns it

Institutions hold the majority of ROIV's shares.

Fund-owned

80.5%

of shares outstanding

Institutions

502

reporting holders

Largest holder

Fmr Llc

latest filing

Recent filing moves13F · quarterly

Fmr Llc
Q1 2026 filing
Added18.6%
Morgan Stanley
Q1 2026 filing
Trimmed11.2%
Blackrock, Inc.
Q1 2026 filing
Added7.5%
Vanguard Group Inc
Q4 2025 filing
Added8.4%
Qvt Financial Lp
Q1 2026 filing
Trimmed4.6%

Financials

FY FY 2026

Revenue$8.26M

Rev growth-71.6%

Operating inc.$-515.07M

Net income$-299.77M

Analyst

Analyst ratings & forecast

BuyTarget $36.53

Based on 9 analysts - 89% rate it a Buy

Implied upside+21.6%Gap to the avg target

Rating mix

Buy 8Hold 1Sell 0

Fundamentals

Fundamentals score

56/ 100

Scores are free · Pro unlocks the call

Composite of valuation, growth, quality & momentum versus sector peers.

Healthcare · Biotechnology

Growth

Momentum

100

Valuation

Quality

stocksbrew Pro

Know when to buy, hold, or sell ROIV

Scores are above. Pro reads the news on ROIV, flags the catalyst, and gives you one daily call plus the full AI brief.

Daily directive: buy, hold, sell, or watch
Big news and headlines tied to the call
Catalysts, earnings, and risks flagged
Sentiment from news, analysts, and the crowd

3 days free, then $12/mo. Cancel anytime.